chr2:201284866:G>C Detail (hg38) (CASP8)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr2:202,149,589-202,149,589 View the variant detail on this assembly version. |
hg38 | chr2:201,284,866-201,284,866 |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_001228.4:c.904G>C | NP_001219.2:p.Asp302His |
NM_033356.3:c.808G>C | NP_203520.1:p.Asp270His | |
NM_001080125.1:c.1030G>C | NP_001073594.1:p.Asp344His |
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
JP | HGVD:0.001 |
ToMMo:[No Data.] | |
NCBN:[No Data.] | |
NCBN(Hondo):[No Data.] | |
NCBN(Ryukyu):[No Data.] | |
East asia | ExAC:<0.001 |
Prediction
ClinVar
Clinical Significance |
![]() |
Review star | ![]() |
Show details |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2007-03-01 | no assertion criteria provided | Breast cancer, protection against |
![]() |
Detail |
![]() |
2024-02-01 | criteria provided, multiple submitters, no conflicts | autoimmune lymphoproliferative syndrome type 2B |
![]() |
Detail |
![]() |
2016-03-28 | criteria provided, single submitter | not specified |
![]() |
Detail |
![]() |
2015-03-03 | criteria provided, single submitter | not provided |
![]() ![]() |
Detail |
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
neuroblastoma | B |
![]() |
![]() |
Poor Outcome | Common Germline | 3 | 25502557 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.049 | Malignant neoplasm of breast | Polymorphisms in CASP8 at 2q33.1 have been associated with the risk of developin... | BeFree | 18362937 | Detail |
0.049 | Malignant neoplasm of breast | Both approaches showed statistically significant decreased breast cancer risks f... | BeFree | 19367188 | Detail |
0.080 | breast carcinoma | The minor allele of CASP8 D302H was significantly associated with a reduced risk... | BeFree | 20978178 | Detail |
0.080 | breast carcinoma | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and B... | BeFree | 19214744 | Detail |
<0.001 | Disorder of Achilles tendon | A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) ... | BeFree | 22588838 | Detail |
0.049 | Malignant neoplasm of breast | As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mu... | BeFree | 16251207 | Detail |
0.009 | breast carcinoma | The minor allele of CASP8 D302H was significantly associated with a reduced risk... | BeFree | 20978178 | Detail |
<0.001 | Disorder of Achilles tendon | This study indicates the independent association of CASP8_rs1045485 and CASP8_rs... | BeFree | 22588838 | Detail |
0.009 | breast carcinoma | CASP8 D302H was found to be only associated with breast cancer risk. | BeFree | 25553350 | Detail |
0.082 | ovarian carcinoma | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
0.049 | Malignant neoplasm of breast | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and B... | BeFree | 19214744 | Detail |
0.080 | Central neuroblastoma | A missense SNP in exon 10 of the CASP8 gene SNP D302H was associated with worse ... | BeFree | 25502557 | Detail |
0.049 | Malignant neoplasm of breast | The minor allele of CASP8 D302H was significantly associated with a reduced risk... | BeFree | 20978178 | Detail |
<0.001 | Meningioma, benign, no ICD-O subtype | CASP8 D302H and meningioma risk: an analysis of five case-control series. | BeFree | 18823701 | Detail |
0.480 | Malignant neoplasm of breast | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and B... | BeFree | 19214744 | Detail |
0.049 | Malignant neoplasm of breast | CASP8 D302H was found to be only associated with breast cancer risk. | BeFree | 25553350 | Detail |
0.049 | Malignant neoplasm of breast | In multivariate analyses, we observed a significantly decreased risk of breast c... | BeFree | 17932347 | Detail |
0.360 | Malignant neoplasm of breast | The minor allele of CASP8 D302H was significantly associated with a reduced risk... | BeFree | 20978178 | Detail |
<0.001 | breast carcinoma | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
0.017 | breast carcinoma | Ten SNPs (rs2075555 in COL1A1, rs12652447 in FBXL17, rs10941679 in 5p12/MRPS30, ... | BeFree | 24528085 | Detail |
<0.001 | ovarian carcinoma | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
<0.001 | Disorder of Achilles tendon | A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) ... | BeFree | 22588838 | Detail |
0.001 | breast carcinoma | Previous case-control studies have indicated that the polymorphisms CASP8 D302H ... | BeFree | 20978178 | Detail |
0.026 | Malignant neoplasm of breast | Ten SNPs (rs2075555 in COL1A1, rs12652447 in FBXL17, rs10941679 in 5p12/MRPS30, ... | BeFree | 24528085 | Detail |
0.002 | ovarian carcinoma | In the present study we investigate the relevance of RAD51 -135C > G, TP53 R7... | BeFree | 19214744 | Detail |
0.011 | colorectal cancer | CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal... | BeFree | 18362937 | Detail |
0.001 | pancreatic carcinoma | CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0... | BeFree | 19843670 | Detail |
<0.001 | Tendinopathy | A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) ... | BeFree | 22588838 | Detail |
0.006 | Malignant neoplasm of ovary | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
0.011 | Central neuroblastoma | CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified ... | BeFree | 25502557 | Detail |
0.005 | prostate carcinoma | Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate... | BeFree | 20033885 | Detail |
<0.001 | Breast Cancer, Familial | Association of the CASP10 V410I variant with reduced familial breast cancer risk... | BeFree | 16251207 | Detail |
0.006 | Malignant neoplasm of ovary | In the present study we investigate the relevance of RAD51 -135C > G, TP53 R7... | BeFree | 19214744 | Detail |
0.049 | Malignant neoplasm of breast | The CASP8 polymorphism D302H has recently been shown to influence the risk of br... | BeFree | 18823701 | Detail |
0.009 | breast carcinoma | As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mu... | BeFree | 16251207 | Detail |
<0.001 | Carcinogenesis | As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mu... | BeFree | 16251207 | Detail |
0.009 | breast carcinoma | Recent work in breast carcinoma has implicated the histidine variant of CASP8 D3... | BeFree | 20033885 | Detail |
0.049 | Malignant neoplasm of breast | Recent work in breast carcinoma has implicated the histidine variant of CASP8 D3... | BeFree | 20033885 | Detail |
0.009 | breast carcinoma | Polymorphisms in CASP8 at 2q33.1 have been associated with the risk of developin... | BeFree | 18362937 | Detail |
0.002 | ovarian carcinoma | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
0.132 | Malignant neoplasm of breast | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
0.001 | Malignant neoplasm of pancreas | CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0... | BeFree | 19843670 | Detail |
0.280 | Malignant neoplasm of ovary | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
0.010 | chronic lymphocytic leukemia | After adjustment for multiple testing, we found a strong association between CLL... | BeFree | 19074885 | Detail |
0.006 | chronic lymphocytic leukemia | After adjustment for multiple testing, we found a strong association between CLL... | BeFree | 19074885 | Detail |
0.001 | pancreatic carcinoma | CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0... | BeFree | 19843670 | Detail |
0.280 | Malignant neoplasm of ovary | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
0.005 | colorectal carcinoma | CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal... | BeFree | 18362937 | Detail |
0.009 | Glioma | The common D302H variant of CASP8 is associated with risk of glioma. | BeFree | 18398042 | Detail |
0.082 | ovarian carcinoma | The p.Asp302His CASP8 variant was associated with reduced ovarian cancer risk in... | BeFree | 20502973 | Detail |
0.006 | meningioma | CASP8 D302H and meningioma risk: an analysis of five case-control series. | BeFree | 18823701 | Detail |
0.001 | breast carcinoma | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
0.009 | breast carcinoma | The CASP8 polymorphism D302H has recently been shown to influence the risk of br... | BeFree | 18823701 | Detail |
0.280 | Malignant neoplasm of ovary | The p.Asp302His CASP8 variant was associated with reduced ovarian cancer risk in... | BeFree | 20502973 | Detail |
0.360 | Malignant neoplasm of breast | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and B... | BeFree | 19214744 | Detail |
0.003 | Malignant neoplasm of ovary | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
0.003 | chronic lymphocytic leukemia | After adjustment for multiple testing, we found a strong association between CLL... | BeFree | 19074885 | Detail |
0.080 | breast carcinoma | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and B... | BeFree | 19214744 | Detail |
0.001 | Malignant neoplasm of breast | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
0.006 | Malignant neoplasm of breast | Previous case-control studies have indicated that the polymorphisms CASP8 D302H ... | BeFree | 20978178 | Detail |
0.080 | ovarian carcinoma | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian... | BeFree | 20978178 | Detail |
<0.001 | Cancer of Head and Neck | A CASP8 promoter region six-nucleotide deletion/insertion (-652 6N ins/del) vari... | BeFree | 20086182 | Detail |
<0.001 | Brain Tumor, Primary | The association of CASP8 D302H with glioma risk indicates the importance of inhe... | BeFree | 18398042 | Detail |
<0.001 | Tendinopathy | A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) ... | BeFree | 22588838 | Detail |
0.005 | prostate carcinoma | Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate canc... | BeFree | 25292051 | Detail |
0.005 | Malignant neoplasm of prostate | Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate canc... | BeFree | 25292051 | Detail |
0.003 | Carcinogenesis | As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mu... | BeFree | 16251207 | Detail |
<0.001 | Multiple tumors | Polymorphisms in CASP8 at 2q33.1 have been associated with the risk of developin... | BeFree | 18362937 | Detail |
0.003 | breast carcinoma | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
<0.001 | Tendinopathy | A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) ... | BeFree | 22588838 | Detail |
0.080 | breast carcinoma | The minor allele of CASP8 D302H was significantly associated with a reduced risk... | BeFree | 20978178 | Detail |
0.009 | breast carcinoma | Both approaches showed statistically significant decreased breast cancer risks f... | BeFree | 19367188 | Detail |
0.005 | chronic lymphocytic leukemia | After adjustment for multiple testing, we found a strong association between CLL... | BeFree | 19074885 | Detail |
0.009 | breast carcinoma | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and B... | BeFree | 19214744 | Detail |
0.124 | chronic lymphocytic leukemia | After adjustment for multiple testing, we found a strong association between CLL... | BeFree | 19074885 | Detail |
0.017 | neuroblastoma | CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified ... | BeFree | 25502557 | Detail |
0.480 | Malignant neoplasm of breast | The minor allele of CASP8 D302H was significantly associated with a reduced risk... | BeFree | 20978178 | Detail |
<0.001 | Breast Cancer, Familial | Association of the CASP10 V410I variant with reduced familial breast cancer risk... | BeFree | 16251207 | Detail |
0.334 | neuroblastoma | A missense SNP in exon 10 of the CASP8 gene SNP D302H was associated with worse ... | BeFree | 25502557 | Detail |
0.001 | Malignant neoplasm of pancreas | CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0... | BeFree | 19843670 | Detail |
0.006 | Malignant neoplasm of breast | As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mu... | BeFree | 16251207 | Detail |
0.123 | Malignant neoplasm of breast | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
0.001 | breast carcinoma | As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mu... | BeFree | 16251207 | Detail |
0.009 | breast carcinoma | In multivariate analyses, we observed a significantly decreased risk of breast c... | BeFree | 17932347 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
21 SNPs were analyzed using qRT-PCR genotyping assays in 500 Neuroblastoma tumor samples, and the CA... | CIViC Evidence | Detail |
NM_001372051.1(CASP8):c.853G>C (p.Asp285His) AND Breast cancer, protection against | ClinVar | Detail |
NM_001372051.1(CASP8):c.853G>C (p.Asp285His) AND Autoimmune lymphoproliferative syndrome type 2B | ClinVar | Detail |
NM_001372051.1(CASP8):c.853G>C (p.Asp285His) AND not specified | ClinVar | Detail |
NM_001372051.1(CASP8):c.853G>C (p.Asp285His) AND not provided | ClinVar | Detail |
Polymorphisms in CASP8 at 2q33.1 have been associated with the risk of developing cancer, specifical... | DisGeNET | Detail |
Both approaches showed statistically significant decreased breast cancer risks for CASP8 D302H. | DisGeNET | Detail |
The minor allele of CASP8 D302H was significantly associated with a reduced risk of breast cancer (p... | DisGeNET | Detail |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | DisGeNET | Detail |
A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) and 199 Australia (A... | DisGeNET | Detail |
As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both ... | DisGeNET | Detail |
The minor allele of CASP8 D302H was significantly associated with a reduced risk of breast cancer (p... | DisGeNET | Detail |
This study indicates the independent association of CASP8_rs1045485 and CASP8_rs3834129 as well as t... | DisGeNET | Detail |
CASP8 D302H was found to be only associated with breast cancer risk. | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | DisGeNET | Detail |
A missense SNP in exon 10 of the CASP8 gene SNP D302H was associated with worse overall and event-fr... | DisGeNET | Detail |
The minor allele of CASP8 D302H was significantly associated with a reduced risk of breast cancer (p... | DisGeNET | Detail |
CASP8 D302H and meningioma risk: an analysis of five case-control series. | DisGeNET | Detail |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | DisGeNET | Detail |
CASP8 D302H was found to be only associated with breast cancer risk. | DisGeNET | Detail |
In multivariate analyses, we observed a significantly decreased risk of breast cancer associated wit... | DisGeNET | Detail |
The minor allele of CASP8 D302H was significantly associated with a reduced risk of breast cancer (p... | DisGeNET | Detail |
We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
Ten SNPs (rs2075555 in COL1A1, rs12652447 in FBXL17, rs10941679 in 5p12/MRPS30, rs11878583 in ZNF577... | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) and 199 Australia (A... | DisGeNET | Detail |
Previous case-control studies have indicated that the polymorphisms CASP8 D302H and CASP10 V410I are... | DisGeNET | Detail |
Ten SNPs (rs2075555 in COL1A1, rs12652447 in FBXL17, rs10941679 in 5p12/MRPS30, rs11878583 in ZNF577... | DisGeNET | Detail |
In the present study we investigate the relevance of RAD51 -135C > G, TP53 R72P, NQO1*2 and CASP8... | DisGeNET | Detail |
CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the Unite... | DisGeNET | Detail |
CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0.9; P = 0.005] and M... | DisGeNET | Detail |
A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) and 199 Australia (A... | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patien... | DisGeNET | Detail |
Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. | DisGeNET | Detail |
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction wit... | DisGeNET | Detail |
In the present study we investigate the relevance of RAD51 -135C > G, TP53 R72P, NQO1*2 and CASP8... | DisGeNET | Detail |
The CASP8 polymorphism D302H has recently been shown to influence the risk of breast cancer. | DisGeNET | Detail |
As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both ... | DisGeNET | Detail |
As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both ... | DisGeNET | Detail |
Recent work in breast carcinoma has implicated the histidine variant of CASP8 D302H (rs1045485) as a... | DisGeNET | Detail |
Recent work in breast carcinoma has implicated the histidine variant of CASP8 D302H (rs1045485) as a... | DisGeNET | Detail |
Polymorphisms in CASP8 at 2q33.1 have been associated with the risk of developing cancer, specifical... | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0.9; P = 0.005] and M... | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
After adjustment for multiple testing, we found a strong association between CLL risk and six geneti... | DisGeNET | Detail |
After adjustment for multiple testing, we found a strong association between CLL risk and six geneti... | DisGeNET | Detail |
CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0.9; P = 0.005] and M... | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the Unite... | DisGeNET | Detail |
The common D302H variant of CASP8 is associated with risk of glioma. | DisGeNET | Detail |
The p.Asp302His CASP8 variant was associated with reduced ovarian cancer risk in the familial BRCA1/... | DisGeNET | Detail |
CASP8 D302H and meningioma risk: an analysis of five case-control series. | DisGeNET | Detail |
We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
The CASP8 polymorphism D302H has recently been shown to influence the risk of breast cancer. | DisGeNET | Detail |
The p.Asp302His CASP8 variant was associated with reduced ovarian cancer risk in the familial BRCA1/... | DisGeNET | Detail |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
After adjustment for multiple testing, we found a strong association between CLL risk and six geneti... | DisGeNET | Detail |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | DisGeNET | Detail |
We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
Previous case-control studies have indicated that the polymorphisms CASP8 D302H and CASP10 V410I are... | DisGeNET | Detail |
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA... | DisGeNET | Detail |
A CASP8 promoter region six-nucleotide deletion/insertion (-652 6N ins/del) variant and a coding reg... | DisGeNET | Detail |
The association of CASP8 D302H with glioma risk indicates the importance of inherited variation in t... | DisGeNET | Detail |
A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) and 199 Australia (A... | DisGeNET | Detail |
Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethn... | DisGeNET | Detail |
Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethn... | DisGeNET | Detail |
As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both ... | DisGeNET | Detail |
Polymorphisms in CASP8 at 2q33.1 have been associated with the risk of developing cancer, specifical... | DisGeNET | Detail |
We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
A total of 358 unaffected control (CON) participants [159 South Africa (SA CON) and 199 Australia (A... | DisGeNET | Detail |
The minor allele of CASP8 D302H was significantly associated with a reduced risk of breast cancer (p... | DisGeNET | Detail |
Both approaches showed statistically significant decreased breast cancer risks for CASP8 D302H. | DisGeNET | Detail |
After adjustment for multiple testing, we found a strong association between CLL risk and six geneti... | DisGeNET | Detail |
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | DisGeNET | Detail |
After adjustment for multiple testing, we found a strong association between CLL risk and six geneti... | DisGeNET | Detail |
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patien... | DisGeNET | Detail |
The minor allele of CASP8 D302H was significantly associated with a reduced risk of breast cancer (p... | DisGeNET | Detail |
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction wit... | DisGeNET | Detail |
A missense SNP in exon 10 of the CASP8 gene SNP D302H was associated with worse overall and event-fr... | DisGeNET | Detail |
CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0.9; P = 0.005] and M... | DisGeNET | Detail |
As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both ... | DisGeNET | Detail |
We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
As CASP10 and CASP8 functionally co-operate during apoptosis, we analysed the mutual effect of both ... | DisGeNET | Detail |
In multivariate analyses, we observed a significantly decreased risk of breast cancer associated wit... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs1045485 dbSNP
- Genome
- hg38
- Position
- chr2:201,284,866-201,284,866
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- C
- Filtering Status (HGVD)
- PASS
- # of samples (HGVD)
- 1210
- Mean of sample read depth (HGVD)
- 154.64
- Standard deviation of sample read depth (HGVD)
- 72.40
- Number of reference allele (HGVD)
- 2417
- Number of alternative allele (HGVD)
- 3
- Allele Frequency (HGVD)
- 0.0012396694214876034
- Gene Symbol (HGVD)
- CASP8
- East Asian Chromosome Counts (ExAC)
- 8654
- East Asian Allele Counts (ExAC)
- 3
- East Asian Heterozygous Counts (ExAC)
- 3
- East Asian Homozygous Counts (ExAC)
- 0
- East Asian Allele Frequency (ExAC)
- 3.4666050381326557E-4
- Chromosome Counts in All Race (ExAC)
- 121386
- Allele Counts in All Race (ExAC)
- 11008
- Heterozygous Counts in All Race (ExAC)
- 9722
- Homozygous Counts in All Race (ExAC)
- 643
- Allele Frequency in All Race (ExAC)
- 0.09068591106058359
- Variant (CIViC) (CIViC Variant)
- D302H
- Transcript 1 (CIViC Variant)
- ENST00000264275.5
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/650
Genome browser